Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 4/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21224620 | 0.97 | ALDH1A1 (0.31) | — | |
| SCHEMBL20772172 | 0.91 | — | — | |
| SCHEMBL6284651 | 0.73 | DHODH (0.41) | — | |
| SCHEMBL7009105 | 0.71 | — | — | |
| SCHEMBL7848247 | 0.70 | SLC6A3 (0.39) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL21700372 | 0.68 | NISCH (0.45) | SLC6A4SLC6A3SLC6A2EPHX2 | |
| SCHEMBL1765599 | 0.63 | ALDH1A1 (0.35) | — | |
| SCHEMBL13737387 | 0.59 | ALDH1A1 (0.33) | — | |
| SCHEMBL566960 | 0.58 | — | — | |
| SCHEMBL11579050 | 0.58 | TSHR (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111630031-B | Process for producing quinolin-4 (1H) -one derivative | 日本化药株式会社 | 2024-03-12 | — | — | CN | disclosed |
| CN-115052856-A | 3-alkoxybenzamide derivative and pest control agent | 组合化学工业株式会社 | 2022-09-13 | — | — | CN | disclosed |
| CN-114650991-A | Bridged ring-fused aldehyde pyridine derivative and application thereof | 北京伯汇生物技术有限公司 | 2022-06-21 | — | — | CN | disclosed |
| US-11267787-B2 | Method for producing quinolin-4(1H)-one derivative | NIPPON KAYAKU CO., LTD (JP) | 2022-03-08 | — | — | US | disclosed |
| WO-2021153720-A1 | 3-ALKOXY BENZOIC ACID AMIDE DERIVATIVE, AND PEST CONTROL AGENT | クミアイ化学工業株式会社 | 2021-08-05 | — | — | WO | disclosed |
| CN-112759593-A | Bridged ring-fused aldehyde pyridine derivative and application thereof | 北京伯汇生物技术有限公司 | 2021-05-07 | — | — | CN | disclosed |
| US-20210070710-A1 | METHOD FOR PRODUCING QUINOLIN-4(1H)-ONE DERIVATIVE | NIPPON KAYAKU CO., LTD. (JP) | 2021-03-11 | — | — | US | disclosed |
| US-20200392107-A1 | CYCLIC AMINE DERIVATIVE AND MEDICAL USE THEREOF | TORAY INDUSTRIES, INC. (JP) | 2020-12-17 | — | — | US | disclosed |
| EP-3747879-A1 | CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | Toray Industries, Inc. (JP) | 2020-12-09 | — | — | EP | disclosed |
| CN-111630031-A | Process for producing quinolin-4 (1H) -one derivative | 日本化药株式会社 | 2020-09-04 | — | — | CN | disclosed |
| CN-111566098-A | Cyclic amine derivatives and pharmaceutical use thereof | 东丽株式会社 | 2020-08-21 | — | — | CN | disclosed |
| WO-2019151270-A1 | CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | 東レ株式会社 | 2019-08-08 | — | — | WO | disclosed |
| EP-1607463-B1 | LIQUID CRYSTAL COMPOSITION | DAINIPPON INK & CHEMICALS (JP) | 2008-09-24 | — | — | EP | disclosed |
| US-7405026-B2 | Liquid crystal composition | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2008-07-29 | — | — | US | disclosed |
| US-20060172089-A1 | Liquid crystal composition | DAINIPPON INK AND CHEMICALS, INC., (JP) | 2006-08-03 | — | — | US | disclosed |
| EP-1607463-A1 | LIQUID CRYSTAL COMPOSITION | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-12-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11267787-B2 | Method for producing quinolin-4(1H)-one derivative | NQO2, AKR7A2, KEAP1 | SLC6A4 2977/4885SLC6A3 4172/4885SLC6A2 3382/4885 |
| US-20200392107-A1 | CYCLIC AMINE DERIVATIVE AND MEDICAL USE THEREOF | NPR3, SLC10A1, CNR2 | SLC6A4 251/4885SLC6A3 88/4885SLC6A2 53/4885 |
| US-20210070710-A1 | METHOD FOR PRODUCING QUINOLIN-4(1H)-ONE DERIVATIVE | NQO2, AKR7A2, KEAP1 | SLC6A4 2977/4885SLC6A3 4172/4885SLC6A2 3382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.